01789.HK
AK Medical Holdings Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 5.02
+1.31%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.9B | 1.5B | 1.3B | 1.1B | 1.1B |
| Cost of Revenue | 1.1B | 585.0M | 538.2M | 419.4M | 415.6M |
| Gross Profit | 1.8B | 897.4M | 808.2M | 674.5M | 636.4M |
| Operating Expenses | |||||
| R&D Expense | 289.2M | 141.6M | 139.2M | 137.1M | 110.9M |
| SG&A Expense | 814.8M | 417.6M | 384.9M | 352.2M | 298.4M |
| General & Admin Expense | 302.9M | 152.0M | 143.9M | 133.4M | 118.3M |
| Selling & Marketing Expense | 514.7M | 265.6M | 240.9M | 218.8M | 180.1M |
| Other Expenses | (49.5M) | (35.7M) | (16.7M) | (26.4M) | 7.2M |
| Total Operating Expenses | 1.1B | 523.5M | 507.4M | 463.0M | 416.5M |
| Cost and Expenses | 2.2B | 1.1B | 1.0B | 882.4M | 832.1M |
| Operating Income (EBIT) | 733.3M | 373.9M | 300.8M | 211.5M | 220.0M |
| Non-Operating | |||||
| Interest Income | 51.5M | 29.4M | 23.4M | 22.8M | 17.8M |
| Interest Expense | 2.6M | 2.9M | 923.0K | 1.3M | 2.2M |
| Net Interest Income | 47.2M | 26.4M | 22.4M | 21.5M | 15.6M |
| Other Non-Op Income/Expense | 45.6M | 21.1M | 19.0M | 19.6M | 20.3M |
| Non-Operating Income (excl Interest) | — | — | (20.0M) | (20.9M) | (22.5M) |
| EBT (Pre-Tax Income) | 778.8M | 395.0M | 319.8M | 231.1M | 240.3M |
| Income Tax Expense | 111.1M | 55.9M | 45.9M | 49.0M | 35.5M |
| Bottom Line | |||||
| Net Income | 667.8M | 339.1M | 273.9M | 182.1M | 204.8M |
| Earnings from Cont. Ops | 670.5M | 339.1M | 273.9M | 182.1M | 204.8M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 667.8M | 339.1M | 273.9M | 182.1M | 204.8M |
| Per Share | |||||
| Basic EPS | HK$0.60 | HK$0.30 | HK$0.25 | HK$0.16 | HK$0.18 |
| Diluted EPS | HK$0.60 | HK$0.30 | HK$0.24 | HK$0.16 | HK$0.18 |
| Revenue Per Share | HK$2.63 | HK$1.32 | HK$1.21 | HK$0.98 | HK$0.95 |
| Shares | |||||
| Basic Shares Outstanding | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| Diluted Shares Outstanding | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B |
| Profitability Metrics | |||||
| EBITDA | 839.1M | 465.3M | 371.7M | 323.3M | 322.9M |
| D&A | 151.6M | 91.5M | 70.9M | 90.9M | 80.4M |
| EBIT | 733.3M | 373.9M | 300.8M | 232.4M | 242.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026